Clonal Hematopoiesis of Indeterminate Potential: New Insights from Recent Studies

Clonal hematopoiesis of indeterminate potential (CHIP) is a condition characterized by accumulation of one or several somatic mutations in hematopoietic stem cells in the bone marrow. Recent studies have provided new data on the prevalence of CHIP mutations, which are relatively common in both cance...

Full description

Saved in:
Bibliographic Details
Main Author: Adrian Schmidt
Format: Article
Language:English
Published: THE HEALTHBOOK COMPANY LTD. 2021-10-01
Series:healthbook TIMES. Oncology Hematology
Online Access:https://doi.org/10.36000/hbT.OH.2021.09.042
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849711239581663232
author Adrian Schmidt
author_facet Adrian Schmidt
author_sort Adrian Schmidt
collection DOAJ
description Clonal hematopoiesis of indeterminate potential (CHIP) is a condition characterized by accumulation of one or several somatic mutations in hematopoietic stem cells in the bone marrow. Recent studies have provided new data on the prevalence of CHIP mutations, which are relatively common in both cancer patients and the general population, and especially in older adults. Adverse clinical outcomes pertaining to hematopoietic clonality have also been observed in asymptomatic, apparently healthy individuals, such as cytopenia, cardiovascular complications, and/or overt blood cancers. However, there are currently no consensus guidelines on screening or monitoring for CHIP. New insights from recent studies will help to identify subgroups of patients who will benefit from routine CHIP screening, preventative measures, and early tailored intervention.
format Article
id doaj-art-c8ac28c17dfd4ca0ae360fbc1492b999
institution DOAJ
issn 2673-2092
2673-2106
language English
publishDate 2021-10-01
publisher THE HEALTHBOOK COMPANY LTD.
record_format Article
series healthbook TIMES. Oncology Hematology
spelling doaj-art-c8ac28c17dfd4ca0ae360fbc1492b9992025-08-20T03:14:40ZengTHE HEALTHBOOK COMPANY LTD.healthbook TIMES. Oncology Hematology2673-20922673-21062021-10-019310.36000/hbT.OH.2021.09.042Clonal Hematopoiesis of Indeterminate Potential: New Insights from Recent StudiesAdrian SchmidtClonal hematopoiesis of indeterminate potential (CHIP) is a condition characterized by accumulation of one or several somatic mutations in hematopoietic stem cells in the bone marrow. Recent studies have provided new data on the prevalence of CHIP mutations, which are relatively common in both cancer patients and the general population, and especially in older adults. Adverse clinical outcomes pertaining to hematopoietic clonality have also been observed in asymptomatic, apparently healthy individuals, such as cytopenia, cardiovascular complications, and/or overt blood cancers. However, there are currently no consensus guidelines on screening or monitoring for CHIP. New insights from recent studies will help to identify subgroups of patients who will benefit from routine CHIP screening, preventative measures, and early tailored intervention.https://doi.org/10.36000/hbT.OH.2021.09.042
spellingShingle Adrian Schmidt
Clonal Hematopoiesis of Indeterminate Potential: New Insights from Recent Studies
healthbook TIMES. Oncology Hematology
title Clonal Hematopoiesis of Indeterminate Potential: New Insights from Recent Studies
title_full Clonal Hematopoiesis of Indeterminate Potential: New Insights from Recent Studies
title_fullStr Clonal Hematopoiesis of Indeterminate Potential: New Insights from Recent Studies
title_full_unstemmed Clonal Hematopoiesis of Indeterminate Potential: New Insights from Recent Studies
title_short Clonal Hematopoiesis of Indeterminate Potential: New Insights from Recent Studies
title_sort clonal hematopoiesis of indeterminate potential new insights from recent studies
url https://doi.org/10.36000/hbT.OH.2021.09.042
work_keys_str_mv AT adrianschmidt clonalhematopoiesisofindeterminatepotentialnewinsightsfromrecentstudies